Dachaigh › Galar Ae Steatotic › California
Sgrùdaidhean clionaigeach Galar Ae Steatotic ann an California
Tha 22 sgrùdaidhean airson Galar Ae Steatotic a’ lorg phàirtichean aig làraichean ann an California.
Bailtean ann an California
- San Diego14 sgrùdaidhean
- Pasadena8 sgrùdaidhean
- Los Angeles8 sgrùdaidhean
- Lancaster7 sgrùdaidhean
- Orange5 sgrùdaidhean
- San Francisco5 sgrùdaidhean
- Huntington Beach5 sgrùdaidhean
- Fresno5 sgrùdaidhean
- Rialto5 sgrùdaidhean
- Long Beach4 sgrùdaidhean
- Folsom4 sgrùdaidhean
- Escondido3 sgrùdaidhean
- Sacramento3 sgrùdaidhean
- Santa Maria3 sgrùdaidhean
- Simi Valley3 sgrùdaidhean
Teacsa sgrùdaidh oifigeil (Beurla)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Camarillo
- 89bio Clinical Study Site, Canoga Park
- 89bio Clinical Study Site, Coronado
- agus 10 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Canoga Park
- 89bio Clinical Study Site, Coronado
- 89bio Clinical Study Site, Escondido
- agus 13 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06318169A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Folsom
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Folsom
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07701993A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Southern California Research Center, Coronado
- California Liver Research Institute, Pasadena
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07527910Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- University of California San Diego NAFLD Research Center, La Jolla
- Keck Medical Center of USC, Los Angeles
- LAC + USC Medical Center, Los Angeles
- agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05832229A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Southern California Research Center, Coronado
- Om Research Llc, Lancaster
- Clinnova Research Solutions, Orange
- agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- San Fernando Valley Health Institute, Canoga Park
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Fresno Clinical Research Center, Fresno
- agus 11 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Coronado
- Akero Clinical Study Site, Escondido
- Akero Clinical Study Site, Folsom
- agus 13 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Arcadia
- GSK Investigational Site, Covina
- GSK Investigational Site, Los Angeles
- agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Om Research, Apple Valley
- ARK Clinical Research - Fountain Valley, Fountain Valley
- UCSD Medical Center, La Jolla
- agus 4 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07288138A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Coronado
- GSK Investigational Site, Lancaster
- GSK Investigational Site, Los Angeles
- agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06613698A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Arcadia
- GSK Investigational Site, Covina
- GSK Investigational Site, Folsom
- agus 6 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07221227A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Fresno
- GSK Investigational Site, Lancaster
- GSK Investigational Site, Pasadena
- agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT06920043A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
- GSK Investigational Site, Rialto
A’ fastadhÌre 1
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 9 Ògmh 2026 · NCT07358546Bicalutamide Therapy in Young Women With NAFLD and PCOS
- University of California San Francisco, San Francisco
A’ fastadhÌre 1
Aoisean 18 gu 42 · Banairean · Air ùrachadh 29 Cèit 2026 · NCT05979389A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Velocity Clinical research, Los Angeles
A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT05648214Androgens and NAFLD Longitudinal Cohort Study
- University of California San Francisco, San Francisco
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 42 · Banairean · Air ùrachadh 13 Gibl 2026 · NCT06124261Accurate Point of Care Liver Disease Diagnostics (Phase 2)
- University of California San Diego, La Jolla
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Gibl 2026 · NCT07518784Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
- University of California San Diego, La Jolla
A’ fastadhSgrùdadh amharc
Aoisean 9 gu 18 · Gach gnè · Air ùrachadh 21 Faoi 2026 · NCT06706856Implementing Food Referrals for Equity and Sustained Health
- Rady Children's Hospital San Diego, San Diego
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
Aoisean 5 agus nas sine · Gach gnè · Air ùrachadh 19 Samh 2025 · NCT06661538Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Stanford University, Stanford
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 35 gu 65 · Gach gnè · Air ùrachadh 4 Dùbh 2024 · NCT05165706Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.